Circulating subsets in major depression and dysthymia with typical or atypical features

Psychosomatic Medicine

Volumn 60, Issue 3, 1998, Pages 283-289

  Ravindran, Arun V ^b   Griffiths, Jenna ^c   Merali, Zul ^c   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NONE

Author keywords

Atypical; Depression; Dysthymia; Immune; NK cells

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DYSTHYMIA; FEMALE; HELPER CELL; HUMAN; IMMUNOMODULATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; B LYMPHOCYTE; FLOW CYTOMETRY; IMMUNOLOGY; MAJOR DEPRESSION; MIDDLE AGED; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY;

ADULT; B-LYMPHOCYTE SUBSETS; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHONEUROIMMUNOLOGY; T-LYMPHOCYTE SUBSETS;

EID: 0032065334     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199805000-00013     Document Type: Article

References (40)

1. Irwin MR, Caldwell C, Smith TL, et al: Major depressive disorder, alcoholism, and reduced natural killer cytotoxicity: Role of severity of depressive symptoms and alcohol consumption. Arch Gen Psychiatry 47:713-719, 1990
2. Maes M: Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11-38, 1995
3. Miller AH, Spencer RL, McEwen BS, et al: Depression, adrenal steroids, and the immune system. Ann Med 25:481-487, 1993
4. Herbert TB, Cohen S: Depression and immunity: A meta-analytic review. Psychol Bull 113:472-486, 1993
5. Stein M, Miller, AH, Trestman RL: Depression, the immune system, and health. Arch Gen Psychiatry 48:171-177, 1991
6. Weisse CS: Depression and immunocompetence: A review of the literature. Psychol Bull 113:475-486, 1992
7. Brosschot JR, Benschop RJ, Godaert GLR, et al: Effects of experimental psychological stress on distribution and function of peripheral blood cells. Psychosom Med 54:394-406, 1992
8. Dhabhar FS, McEwen BS: Stress-induced enhancement of antigen-specific cell-mediated immunity. J Immunol 156:2608-2615, 1996
9. Dhabhar FS, Miller AH, McEwen BS, et al: Effects of stress on immune cell distribution: Dynamic and hormonal mechanisms. J Immunol 154:5511-5527, 1995
10. Macs M, Lambrechts J, Suy E, et al: Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression. Neuropsychobiology 29:157-163, 1994
11. Maes M, Meltzer HY, Stevens WIM, et al: Natural killer cell activity in major depression: Relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry 18:717-730, 1994
12. Ravindran, AV, Griffiths J, Merali Z, et al: Lymphocyte subsets associated with major depression and dysthymia: Modification by antidepressant treatment. Psychosom Med 57:555-563, 1995
13. Seidel A, Arolt V, Huntstiger M, et al: Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78:83-85, 1996
14. Irwin M, Mascovich A, Gillin JC, et al: Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom Med 56:493-498, 1994
15. Moldofsky H: Sleep and the immune system. Int J Immunopharmacol 17:649-654, 1995
16. Asnis GM, McGinn LK, Sanderson WC: Atypical depression: Clinical aspects and noradrenergic function. Am J Psychiatry 152:31-36, 1995
17. McGinn LK, Asnis GM, Rubinson E: Biological and clinical validation of atypical depression. Psychiatry Res 60:191-198, 1996
18. McGrath P, Stewart J, Harrison W, et al: Predictive value of symptoms of atypical depression for differential drug outcome. J Clin Psychopharmacol 12:197-202, 1992
19. Beckham EE, Leber WR, Youll LK: The diagnostic classification of depression. In Beckham EE, Leber WR (eds), Handbook of Depression. New York, Guilford Press, 1995
20. Akiskal HS: Dysthymic disorder: Psychopathology of proposed chronic depressive subtypes. Am J Psychiatry 140:11-20, 1983
21. Rowland RH, Thase ME: Biological studies of dysthymia. Biol Psychiatry 30:283-304, 1991
22. Ravindran AV, Merali Z, Anisman H: Dysthymia: A biological perspective. Licinio J, Bolis CL, Gold P (eds), Dysthymia: From Clinical Neuroscience Treatment. Geneva, World Health Organization, 1997
23. Akiskal HS: Towards a definition of dysthymia: boundaries with personality and mood disorders. In Burton SW, Akiskal HS (eds) Dysthymic Disorders. London, Gaskell, 1990
24. Beck AT, Ward CH, Mendelson M, et al: An inventory for measuring depression. Arch Gen Psychiatry 4:561-569, 1961
25. Ravindran, AV, Griffiths J, Merali Z, et al: Primary dysthymia: A study of several psychosocial, endocrine and immune correlates. J Affect Dis 40:73-84, 1996
26. Ravindran, AV, Griffiths J, Merali Z, et al: Variation of lymphocyte subsets associated with stress in depressive populations. Psychoneuroendocrinology 21:659-671, 1997
27. Andreoli AV, Keller SE, Rabaeus M, et al: Depression and immunity: Age, severity, and clinical course. Brain Behav Immunol 7:279-292, 1993
28. Evans DL, Folds JD, Petitto JM, et al: Circulating natural killer cell phenotypes in men and women with major depression. Arch Gen Psychiatry 49:388-395, 1992
29. Darko DF, Lucas AH, Gillin JC, et al: Cellular immunity and the hypothalamic pituitary axis in major affective disorder: A preliminary study. Psychiatr Res 25:1-9, 1988
30. Billings AG, Moos RH: Life stressors and social resources affect posttreatment outcomes among depressed patients. J Abnorm Psychol 94:140-153, 1985
31. Brown GW, Harris TO: Life Events and Illness. New York, Guilford Press, 1989
32. Lazarus RS: Coping theory and research: Past, present, and future. Psychosom Med 55:234-247, 1993
33. Griffiths J, Ravindran AV, Merali Z, et al: Immune and behavioral correlates of typical and atypical depression. Soc Neurosci Abstr 22:1350, 1996
34. Ravindran AV, Griffiths J, Merali Z, et al: Immune correlates in subtypes of depressive disorders. Soc Neurosci Abstr 22:1350, 1996
35. Demitrack MA, Dale JK, Straus SE, et al: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 148: 337-344, 1991
36. Gold PW, Licinio J, Wong ML, et al: Corticotropin releasing hormone in pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. New York Acad Sci 771:716-729, 1995
37. Dunn AJ: Interactions between the nervous system and the immune system: Implications for psychopharmacology. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress, New York, Raven Press, 1995
38. Kiecolt-Glaser JK, Cacioppo JT, Malarkey WB, et al: Acute psychological stressors and short-term immune changes: What, why, for whom, and to what extent? Psychosom Med 54:680-685, 1992
39. Post RM, Weiss SRB: The neurobiology of treatment-resistant mood disorders. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress, New York, Raven Press, 1995
40. Tilders FJH, Schmidt ED, De Goeij DCE: Phenotypic plasticity of CRF neurons during stress. Ann NY Acad Sci 697:39-52, 1993